Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amino] isonicotinamide hydrochloride

EU orphan designation number: EU/3/10/824   
Active ingredient: N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amino] isonicotinamide hydrochloride
Indication: Treatment of acute myeloid leukaemia
Sponsor: Merck KGaA
Frankfurter Straße 250, 64293 Darmstadt, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/12/2010 Orphan designation EMA/OD/094/10 (2010)9537 of 17/12/2010